Sign in →

Test ID GNRG Gram-Negative Bacillus Antimicrobial Resistance Genes, PCR Panel

Secondary ID

64721

Useful For

Characterizing the molecular mechanisms of antimicrobial resistance in Gram-negative bacilli to explain unusual phenotypic susceptibility profiles or for epidemiologic purposes. The panel detects the following beta-lactamase enzyme producing genes:

Carbapenemase Genes:

GES (Carbapenemase)

GIM

IMP

KPC

NDM

OXA-23 like

OXA-24 like

OXA-48 like

OXA-58 like

SPM

VIM

 

ESBL Genes:

BEL

CTX-M1 Group

CTX-M2 Group

CTX-M9 Group

CTX-M8/25 Group

GES (ESBL)

PER

SHV

TEM

VEB

 

AmpC Genes:

ACC

ACT/MIR

CMY MOX

CMYII

DHA

FOX

Method Name

Multiplex Polymerase Chain Reaction (PCR) with Microarray Detection of Amplified Products

Reporting Name

Gram-Negative Resistance Genes, PCR

Specimen Type

Varies

Collection Container/Tube: Slant isolate

Collection Instructions:

1. Isolate infecting bacteria.

2. Organism must be in pure culture, actively growing. Do not submit mixed cultures.

3. Place specimen in a large infectious container (Supply T146) and label as an etiologic agent/infectious substance.

Additional Information:

1. Organism identification and specimen source are required for processing.

2. Organism identification must be provided. If organism identification is unknown, concomitantly order IDENT / Organism Referred for Identification, Aerobic Bacteria.

3. Relevant susceptibility results may be provided (eg, meropenem resistant, cefepime resistant).

4. If susceptibility testing is needed; also order ZMMLS / Antimicrobial Susceptibility, Aerobic Bacteria, MIC.

5. See Infectious Specimen Shipping Guidelines in Special Instructions for shipping information.

Forms: If not ordering electronically, complete, print, and send a Microbiology Test Request Form (T244) with the specimen (http://www.mayomedicallaboratories.com/it-mmfiles/microbiology_test_request_form.pdf).

Specimen Stability Information

Specimen Type Temperature Time
Varies Ambient (preferred)
  Refrigerated 

Clinical Information

The Check-MDR CT103XL panel, which is performed on bacterial isolates, detects 27 genes associated with antimicrobial resistance in Gram-negative bacilli.

 

Antibiotic resistance is evolving as a result of use and overuse of antibacterial agents. Characterizing the molecular mechanisms of antimicrobial resistance can be helpful to explain unusual phenotypic susceptibility profiles or for epidemiologic purposes. A myriad of beta-lactamase enzymes may be found in Gram-negative bacteria; these enzymes hydrolyze (break down) the beta-lactam ring of beta-lactam antibiotics, destroying their antibacterial activity. A single bacterial isolate may carry 1 or more genes that code for the production of a beta-lactamase enzyme. Beta-lactamases can be on the chromosome or on plasmids and may be classified as extended-spectrum beta-lactamases (ESBLs), AmpCs, and carbapenemases, among other types.

 

ESBLs are beta-lactamases with an expanded substrate profile and are typically plasmid-borne. They are capable of hydrolyzing first-, second-, third- and fourth-generation cephalosporins, penicillins, and monobactams. TEM, SHV, and CTX-M genes are the most clinically prevalent.

-TEM and SHV subtypes are derived from the parental sequences by point mutations resulting in amino acid substitutions, which allow the enzymes to hydrolyze a wide range of beta-lactam antibiotics.

-CTX-M genes originate from Kluyvera species and can be separated into 5 different groups based on their amino acid sequence: CTX-M-1, CTX-M-2, CTX-M-9, CTX-M-8, and CTX-M-25.

-VEB, PER, BEL, and GES genes are less common.

 

AmpC cephalosporinases hydrolyze almost all beta-lactam antibiotics including penicillins, cephalosporins, and monobactams and may be chromosomally- or plasmid-encoded. Several Enterobacteriaceae carry a chromosomal copy of an AmpC gene.

AmpC Gene

Origin of Chromosomal Gene

CMY II

Citrobacter freundii

DHA

Morganella morganii

FOX

Aeromonas caviae

ACC

Hafnia alvei

ACT/MIR

Enterobacter cloacae and Enterobacter asburiae

CMY I/MOX

Aeromonas hydrophilia

 

-Plasmid-encoded AmpC genes may be shared among bacteria. Plasmid-encoded AmpC genes may produce a higher amount of beta-lactamase as compared to chromosomally-encoded AmpC genes; knowing the mechanism may be useful in assessing treatment. An AmpC gene detected in a species that does not have a chromosomal AmpC (see table above) suggests that the gene is plasmid-encoded.

 

Carbapenemases show general resistance to all beta-lactam antibiotics including the beta-lactam-beta-lactamase inhibitor combinations and elevated or complete resistance against carbapenem antibiotics. In addition, isolates harboring carbapenemases often have additional beta-lactamase genes and genes for resistance to quinolones and aminoglycosides.

-Klebsiella pneumoniae Carbapenemase (KPC) is a plasmid-encoded carbapenemase first identified in Klebsiella pneumoniae isolates in North America. KPC has since spread to many parts of the world and can be found in several species of the Enterobacteriaceae.

-New Delhi Metallo-beta-lactamase (NDM) was first reported in 2009 from a patient of Indian origin in Sweden. It is prevalent in the Indian subcontinent, but has spread worldwide.

-The oxacillinase group consists of 10 members, of which OXA-48 and OXA-181 are the most prevalent variants. OXA-48 occurs predominantly in Enterobacteriaceae, originated from Shewanella species, and is most prevalent in Europe and the North African subcontinent. Another grouping of OXA-type carbapenemases are found in Acinetobacter species and consists of 3 type members, OXA-23, OXA-24, and OXA-58. Each type has several subtypes.

-VIM, a metallo-beta-lactamase, was first found in 1997 in a Pseudomonas aeruginosa isolate in Verona. It may be found in Enterobacteriaceae and includes at least 38 variants of which the DNA sequences may differ significantly.

-IMP, a metallo-beta-lactamase, was detected in Japan in 1990 (IMP-1) in Pseudomonas aeruginosa. It may be found worldwide in Enterobacteriaceae and includes at least 44 members with varying gene sequences.

-GIM-1 and SPM-1, also metallo-beta-lactamases, are less frequently found carbapenemases. GIM-1 originated in Germany and has been found in Pseudomonas aeruginosa, Enterobacteriaceae, and Acinetobacter spp. SPM-1 producing Pseudomonas aeruginosa is endemic in Brazilian hospitals where it has been associated with numerous outbreaks.

-GES gene family consists of both ESBL-types and carbapenemase types.

 

Content was based on the Check-MDR CT103XL User Manual and reproduced with permission by Wouter de Levita of Check-Points, 2016.

Reference Values

Not applicable

Cautions

The detection of a resistance gene may not imply phenotypic resistance as the gene may not be expressed, may be expressed in low levels, or may be nonfunctional.

 

The assay does not test for all potential beta-lactamase genes.

 

The assay does not detect all mechanisms of resistance to beta-lactam antibiotics. Porin mutations and efflux pumps, for example, are not detected.

 

Due to the high variability of bacterial genomes, it is possible that certain sub-types of beta-lactamases may not be detected.

 

Clinical specimens cannot be tested directly. This test is for bacterial isolates only.

 

The assay does not differentiate between chromosomally or plasmid-encoded genes.

Day(s) Performed

Varies; Batched 1 time per week

Report Available

10 days

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

87150

NY State Approved

No